Date published: 2026-8-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

JK-1 Double Nickase Plasmid (h): sc-408238-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • JK-1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • JK-1 Double Nickase Plasmid (h) and JK-1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting FAM134B. One or both designs may be available
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    JK-1 Double Nickase Plasmid (h)

    sc-408238-NIC
    20 µg
    $410.00

    FAM134B encodes the human protein JK-1, an endoplasmic reticulum (ER)-resident reticulon family member that functions as a selective autophagy receptor in ER-phagy. By linking ER membranes to the autophagy machinery, JK-1 helps maintain ER morphology and proteostasis during stress and contributes to turnover of aberrant ER subdomains. This activity intersects with unfolded protein response signaling, organelle quality control, and broader autophagy pathways that shape cellular homeostasis. Altered FAM134B/JK-1 function has been associated with neurodegeneration and sensory neuropathy phenotypes, making it relevant for mechanistic studies of ER stress susceptibility and autophagy-dependent remodeling.

    JK-1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the FAM134B locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within FAM134B. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt FAM134B function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of FAM134B-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.